4.7 Article

Cardiac MRI to Investigate Myocardial Scar and Coronary Venous Anatomy Using a Slow Infusion of Dimeglumine Gadobenate in Patients Undergoing Assessment for Cardiac Resynchronization Therapy

期刊

JOURNAL OF MAGNETIC RESONANCE IMAGING
卷 33, 期 1, 页码 87-95

出版社

JOHN WILEY & SONS INC
DOI: 10.1002/jmri.22387

关键词

CRT; whole heart MRI; coronary vein; late enhancement; Gd-BOPTA

资金

  1. European Community [224495]
  2. Medical Research Council [G0600698B] Funding Source: researchfish

向作者/读者索取更多资源

Purpose: To evaluate a cardiac MR (CMR) examination with slow infusion of a high-relaxivity contrast agent to visualize coronary venous anatomy (CVA) and myocardial scar in heart failure patients awaiting cardiac resynchronization therapy (CRT). Materials and Methods: Fourteen patients awaiting CRT (seven ischemic cardiomyopathy (ICM) and seven non-ICM) and two with normal LV function underwent CMR on a 1.5 Tesla (T) MR scanner. Dimeglumine-gadobenate was slowly infused. Bolus arrival in the LV was measured by a dynamic electrocardiogram (ECG) -triggered inversion recovery (IR) scan subsequent to starting an ECG-triggered respiratory-navigated three-dimensional (3D) SSFP MR scan with IR preparation to acquire systolic whole-heart anatomy for vein visualization. Delayed contrast-enhanced MR scan was performed to assess myocardial scar. CVA obtained by CMR was compared with Xray venography in 11 patients. CVA and scar were segmented and registered for visual inspection. Results: For all subjects, there was excellent visualization of the CVA. All ICM and one non-ICM patient showed scar. There was excellent correlation between veins seen by CMR and venography. Conclusion: We have demonstrated that slow infusion protocol of dimeglumine-gadobenate can be used to assess both CVA and myocardial scar in a single MR examination. Furthermore, an image overlay technique has been used to show the relationship of scar to the CVA.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据